Page last updated: 2024-10-20

pteridines and Itching

pteridines has been researched along with Itching in 1 studies

Research Excerpts

ExcerptRelevanceReference
"BI 2536 is a potent, highly selective inhibitor of polo-like kinase (Plk) 1."2.78A phase I open-label dose-escalation study of intravenous BI 2536 together with pemetrexed in previously treated patients with non-small-cell lung cancer. ( Chu, QS; Ellis, PM; Fritsch, H; Gaschler-Markefski, B; Gyorffy, S; Laurie, SA; Leighl, N; Munzert, G, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ellis, PM1
Chu, QS1
Leighl, N1
Laurie, SA1
Fritsch, H1
Gaschler-Markefski, B1
Gyorffy, S1
Munzert, G1

Trials

1 trial available for pteridines and Itching

ArticleYear
A phase I open-label dose-escalation study of intravenous BI 2536 together with pemetrexed in previously treated patients with non-small-cell lung cancer.
    Clinical lung cancer, 2013, Volume: 14, Issue:1

    Topics: Administration, Intravenous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma,

2013